Can you get medical cannabis for cancer pain in the UK?
Cancer-related pain and palliative symptom control are among the conditions UK specialists consider. Two things need saying at the outset: this is about symptoms, not about treating cancer, and the randomised evidence in cancer pain is weaker than many people expect.
The short answer
- This is symptom control, not cancer treatment. There is no evidence cannabis treats cancer itself.
- Nabilone is licensed in the UK, but for chemotherapy-induced sickness — not for pain.
- A Cochrane review found no clear benefit of cannabis-based medicines over placebo for cancer pain.
- Your oncology and palliative teams lead. Anything else should be coordinated with them, not around them.
- Interactions matter more here, because most people with cancer pain are on several other medicines.
Is cancer pain treated with medical cannabis in the UK?
Cancer-related pain and palliative symptoms are assessed by specialists, and cancer patients are among those UK private clinics see. Nothing is licensed for cancer pain, and the honest position is that this sits at the edges of symptom control rather than at its centre.
UK cancer pain is managed by oncology and palliative care teams, who have a well-established toolkit — opioids, adjuvant medicines, nerve blocks, radiotherapy for bone pain, and specialist palliative input. Those services should lead. A cannabis-based medicine, if it has a place, sits alongside them for symptoms that persist despite proper treatment.
There is no good evidence that cannabis or cannabinoids treat cancer, shrink tumours, or extend life. Claims to the contrary circulate widely and are not supported by clinical trials. Nothing on this page should delay or displace cancer treatment.
What the evidence actually shows
Cancer pain has been studied in reasonably large randomised trials, and the pooled result is not encouraging. This is one of the few conditions on this site where the evidence is substantial enough to give a fairly confident negative answer.
A Cochrane systematic review of cannabis-based medicines and medical cannabis for adults with cancer pain, published in 2023, pooled the randomised evidence and found no clear benefit over placebo on pain relief, alongside more adverse events. Earlier individual trials of a THC:CBD oromucosal spray in opioid-treated cancer patients produced mixed results, with some signals in secondary analyses that were not confirmed in later, larger studies.
Where cannabis-based medicines are used in palliative settings in the UK, the rationale is usually broader than pain — nausea, appetite, sleep, distress — and is a matter of individual clinical judgement in someone with limited options, not an evidence-based standard of care.
The study behind that paragraph
Häuser W, Welsch P, Radbruch L, Fisher E, Bell RF, Moore RA. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database of Systematic Reviews. 2023;6:CD014915. A systematic review of randomised trials finding no clear benefit over placebo for cancer pain relief, with more adverse events in the treatment groups.
What a specialist will want to see
There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For cancer-related pain they will typically look at:
- Your cancer diagnosis, treatment stage, and who is leading your care
- Whether specialist palliative care has been involved, and what has already been tried for pain
- Your current analgesia, particularly opioid type and dose, and how well it is working
- Which symptom is the priority: pain, nausea, appetite, sleep, or distress
- Your full medicine list, since interactions and combined sedation matter a great deal here
- Whether treatment is realistically going to add to what your existing team can offer
The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?
Risks and reasons a specialist may say no
People with cancer are usually taking several medicines, are often frail, and may have liver or kidney impairment that changes how a medicine is handled. That makes interactions and sedation a bigger issue than in most other conditions on this site.
The Cochrane review also found more adverse events with cannabis-based medicines than placebo in cancer pain — which, in the absence of clear benefit, is the part that should carry weight. Drowsiness, dizziness, confusion, nausea and dry mouth are the common ones. A responsible specialist will coordinate with your oncology or palliative team rather than prescribing in parallel with them, and will be clear that the aim is comfort, not disease control.
If you want to take this further
The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.
The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If cancer-related pain is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.
Frequently asked questions
Can I get medical cannabis for cancer pain in the UK?
It is assessed by specialists, but nothing is licensed for cancer pain and the evidence does not support it as a standard treatment. Cancer pain is led by oncology and palliative care teams, and anything else should be coordinated with them.
Does cannabis treat cancer?
No. There is no good clinical trial evidence that cannabis or cannabinoids treat cancer, shrink tumours or extend life. Claims of that kind are common online and are not supported by the evidence. Cancer treatment should never be delayed or replaced on that basis.
What did the Cochrane review find?
The 2023 Cochrane review of cannabis-based medicines for adults with cancer pain found no clear benefit over placebo for pain relief, and more adverse events in the treatment groups. This is one of the better-studied areas, which makes the negative finding more meaningful than a simple absence of evidence.
Is nabilone available for cancer patients on the NHS?
Yes, but for a specific use: nabilone is licensed in the UK for nausea and vomiting caused by chemotherapy, as an add-on when standard anti-sickness medicines are not enough. NICE recommends it for adults aged 18 and over. That is a different indication from pain.
Sources and further reading
Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.
- Häuser W, et al. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database of Systematic Reviews (2023)
- NICE guideline CSG4: Improving supportive and palliative care for adults with cancer
- Cancer Research UK: Cannabis and cancer
- NICE guideline NG144: Cannabis-based medicinal products
- NHS: Medical cannabis (and cannabis oils)
- House of Commons Library briefing CBP-8355: Medical use of cannabis
- MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use